Objectives Chondroitin sulfate 800 mg/day (CS) pharmaceutical-grade in the management of symptomatic knee osteoarthritis consistent with the European Medicines Agency guideline. Methods A prospective, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback